NCT03362177 2026-02-11
RECITE
Amgen
Phase 3 Completed
Clinical Trials
28 trialsNCT07218926 2026-01-30
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
GlaxoSmithKline
Phase 3 Recruiting
NCT07222800 2026-01-30
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Pfizer
Phase 3 Recruiting
NCT04457297 2026-01-21
ALTAIR
National Cancer Center Hospital East
Phase 3 Completed
NCT05171075 2025-12-19
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3 Active not recruiting
NCT04607421 2025-08-14
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
Pfizer
Phase 3 Active not recruiting
NCT04588246 2025-06-06
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
NRG Oncology
Phase 3 Terminated
NCT06966232 2025-05-11
Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers
Sun Yat-sen University
Phase 3 Recruiting
NCT05646511 2025-04-03
ENSEMBLE
National Cancer Center Hospital East
Phase 3 Recruiting
NCT03464305 2024-03-19
ASPIRIN
University Hospital, Antwerp
Phase 3 Active not recruiting
NCT02753127 2023-11-15
CanStem303C
Sumitomo Pharma America, Inc.
Phase 3 Completed
NCT03674294 2023-02-08
CINV
Sun Yat-sen University
Phase 3 Completed
NCT02322593 2021-12-20
SOLAR
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT03889626 2019-03-26
The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer
Fudan University
Phase 3 Unknown
NCT01996306 2019-01-08
AXEPT
Epidemiological and Clinical Research Information Network
Phase 3 Completed
NCT00254436 2018-10-25
A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00516269 2018-01-03
Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT03303495 2017-10-06
A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC
Sun Yat-sen University
Phase 3 Unknown
NCT02866045 2016-08-15
EUS-FNB vs. Single-incision Needle-knife (SINK) Biopsy for Gastrointestinal SELs
Unity Health Toronto
Phase 3 Unknown
NCT02785523 2016-05-30
Clinical Trial on Ganoderma Spore Lipids Combined With Chemo in Patients With G.I. Cancers
The First Affiliated Hospital of Dalian Medical University
Phase 3 Unknown
NCT02664974 2016-01-27
Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 3 Completed
NCT01423799 2015-11-13
Neoimmune
Société des Produits Nestlé (SPN)
Phase 3 Completed
NCT01269567 2015-07-23
GRECCAR 5
University Hospital, Bordeaux
Phase 3 Completed
NCT01422928 2015-05-25
Acupuncture for the Immune System in Radiation Cancer Patients
British Columbia Cancer Agency
Phase 3 Withdrawn
NCT00455247 2013-06-05
Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects
Société des Produits Nestlé (SPN)
Phase 3 Completed
NCT00513357 2012-12-11
Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00052962 2012-11-22
Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT00798447 2011-06-09
Efficacy and Safety of a PN Regimen Containing n-3 Fatty Acid in Patients Considered After GI Surgery
B. Braun Melsungen AG
Phase 3 Completed